Saliva Proteins May Protect Older People from Influenza

Article

Saliva may be the key to explaining the age and sex bias exhibited by influenza and other diseases, according to a new study. Published in ACS' Journal of Proteome Research, it provides new insights into why older people were better able to fight off the new strains of avian flu and swine flu than younger people.

Zheng Li and colleagues explain that saliva does more than start the process of digesting certain foods. Saliva also contains germ-fighting proteins that are a first-line defense against infections. Scientists already knew that levels of certain glycoproteins proteins with a sugar coating that combat disease-causing microbes differ with age. Li's team took a closer look at how those differences affected vulnerability to influenza.

Their tests of 180 saliva samples from men and women of various ages suggested that seniors, who fought off the bird flu better than the younger groups, might thank their saliva. Glycoproteins in saliva of people age 65 and over were more efficient in binding to influenza than those in children and young adults. The research "may provide useful information to help understand some age-related diseases and physiological phenomenon specific to women or men, and inspire new ideas for prevention and diagnosis of the diseases by considering the individual conditions based primarily on the salivary analysis," the scientists state.

The authors acknowledge funding from the National Science and Technology Major Project and the Foundation of Shaanxi Educational Committee.

Source: American Chemical Society

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content